Tumors of the Endocrine System Flashcards
(128 cards)
The outcomes of SRT vs. fractionated RT in 44 dogs with pituitary masses were recently retrospectively evaluated. During the first 6mo after RT, ___-___% dogs were euthanized because of progressive neurologic signs. The OST was ____. ______ was significantly associated with survival but treatment type was NOT. MST for dogs txvwith fRT was ____ and MST for dogs tx with SRT was ____.
- 18-19%
- OST: 20mo
- younger age
- MST fRT: 25mo
- MST SRT: 17mo
***CT/MRI should be considered at time of diagnosis of PDH in dogs. If NO mass is seen, recommend _________. If a mass is present but < _____ in diameter, recommend medical therapy and repeat imaging in 12-18 months. If a mass is present and > _____ in diameter, recommend RT.
- no mass: medical therapy alone
< 8mm: medical therapy and re-image
>8mm: RT
______ is a somatostatin receptor analog that binds to receptors SST1, SST2, SS, and SST5.
Pasireotide
What is a potential side effect of pasireotide and its frequency of occurrence?
diabetes mellitus - 15%
_______ inhibits degradation of dopamine thereby potentially inhibiting ACTH secretion from the intermediate lobe of the pituitary gland.
Selegiline (Anipryl)
______ is a dopamine D2 receptor agonist that has shown some efficacy in dogs with PDH.
cabergoline
***Trilostane (Vetoryl) is a synthetic corticoid analog that competitively inhibits _______, which is essential for synthesis of cortisol.
3beta-hydroxysteroid dehydrogenase
***Relative size of the pituitary gland is assessed by evaluating pituitary heigh:brain ratio. A P:B ratio > ____ is consistent with pituitary enlargement.
> 0.31
***In the largest cohort to date of 306 dogs with PDH treated with transphenoid hypophysectomy, survival beyond 4 weeks post-op was seen in ____%. MST was ____ and DFI was ____. Recurrence occurred in ___% and recurrence of HAC occurred at median of ____ from surgery.
- 91%
- MST: 26mo
- DFI: 32mo
- recurrence: 27%
- recurrence of HAC: 19mo
In a prospective study of 150 dogs with PDH treated with transsphenoidal hypophysectomy, 4-year survival was ___%, post-operative death occurred in ___%, remission occurred in ___%, and recurrence occurred in ___%. _____ occurred in 53% of dogs undergoing remission (complication). The overall success rate was deemed ___%.
- 4 year survival: 68%
- mortality: 8%
- remission: 85%
- recurrence: 21%
- diabetes insipidus
- success rate: 65%
A study using high-definition video telescope for hypophysectomy of 26 dogs with PDH reported an overall mortality rate of ___%.
19%
A study of 6 dogs with functional macrotumors treated with RT using 40Gy in 10 fractions reported a MST of ____. Neurologic signs resolved in ___% and ACTH levels remained high for ______ after treatment.
- MST: 24mo
- neuro signs resolved: 100%
- ACTH high for at least 1 year
***A retrospective study of RT in dogs with pituitary macroadenomas demonstrated a significantly improved ST and control of neurologic signs in 19 dogs that received RT compared to 27 untreated dogs. The mean ST of treated dogs was ____ with a 1 year survival rate of ___% and 3 year survival rate of ___%. For untreated dogs, mean ST was ____ with a 1 year survival of ___% and 3 year survival of ___%. ____% of dogs with PDH showed resolution of clinical signs of HAC.
Mean ST:
- Treated: 3.8 years
- Untreated: 18mo
1-year survival:
- Treated: 93%
- Untreated: 45%
3-year survival:
- Treated: 55%
- Untreated: 25%
- 35% resolved clinical signs of HAC
Transphenoidal hypophysectomy for treatment of 7 cats with PDH reported a post-operative mortality rate within 2 weeks in ____%. The remaining cats experienced remission.
30%
The prevalence of acromegaly in the average or typical diabetic cat is likely around ___-___% and the prevalence in cats that are difficult to regulate is likely ____%.
- 10-15%
- 30%
What is the sensitivity and specificity of IGF-1 measurement for cats with acromegaly? IGF-1 levels in cats with acromegaly are usually at least ___________. In Europe, serum IGF-1 has a PPV of 95% if > __________.
- Se: 84%
- Sp: 92%
- at least 2x the URL
- > 1000ng/uL
A study reported outcome of surgery in 21 diabetic cats with acromegaly. Post-operative deaths occurred in ___%, ____% experienced reduction in IGF-1 concentrations, and ___% underwent diabetic remission.
- mortality rate: 14%
- 100% reduction of IGF-1
- Diabetic remission: 78%
***A recent study evaluated outcome of SRT delivered in 3 or 4 fractions for 53 cats with acromegaly. oMST was ____, acute effects occurred in ____%, hypothyroidism occurred in ___% months to years after treatment, reduction in insulin dose occurred in ____% and diabetic remission occurred in ____%. The median duration to the lowest insulin dose was ____.
- oMST: ~ 3 years
- acute effects: ~20%
- hypothyroidism: 14%
- reduction of insulin: 95%
- diabetic remission: 32%
- median duration: ~10mo
What somatostatin analog has shown encouraging results in the medical management of cats with acromegaly? What is the most common side effect?
- pasireotide
- diarrhea
What is the MST of cats with acromegaly treated with non-specific therapy?
- MST 21mo
What is the sensitivity and specificity of detection of vascular invasion from adrenal tumors for both AUS and CT?
AUS:
- Se: 80-100%
- Sp: 90%
CT:
- Se: 92%
- Sp: 100%
A size of _____ of an adrenal tumor is more likely to be malignant.
> 2cm
***On histopathology, adrenal carcinoma is less likely to exhibit what characteristics?
- cytoplasmic vacuolization
- EMH
- Fibrin thrombi
What is the vascular invasion rate and metastatic rate of adrenal carcinoma in dogs? Where are the most common sites of metastasis?
- vascular invasion: 20%
- metastasis: 50%
- liver and lungs